Sabtorani, Loyda M.

HRN: 16-06-56  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2025
CEFUROXIME 500MG (TAB)
06/23/2025
06/30/2025
PO
1 Tab
BID
SP NSVD W RMLE
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: